ResearchDx and Proteomics International are pleased to announce the American Medical Association has approved a new dedicated CPT® Proprietary Laboratory Analyses (PLA) code for PromarkerD. This is a significant milestone and a key step toward future reimbursement coverage of the test by both Medicare and private health insurers in the United States.

ASX Release

Leave a Reply

Your email address will not be published. Required fields are marked *